This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/resource/drugbank/drug/DB01740/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01740/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB01740/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01740/identifier/drugbank/

Statements

Subject Item
n2:DB01740
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB01740 n13:DB01740
dcterms:title
2-Amino-4-Butyl-5-Propylselenazole
adms:identifier
n6:SES n7:445180 n8:DB01740 n9:46508709
n3:IUPAC-Name
n4:271B4200-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4206-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4205-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4202-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4203-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4204-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B41FE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B41FC-363D-11E5-9242-09173F13E4C5 n4:271B41FF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B41FD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B420C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B420D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4207-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4208-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B420A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4209-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B420B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4212-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4214-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4215-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4211-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4210-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4213-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4201-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B420E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B420F-363D-11E5-9242-09173F13E4C5